Background: Certain antiretroviral drugs, including efavirenz, have been associated with mitochondrial and oxidative effects in hepatic cells, but quantitative translation from nominal in vitro concentrations to an in vivo effect-site concentration remains uncertain. Methods: A hypothesis-generating physiologically based pharmacokinetic-pharmacodynamic (PBPK-PD) framework integrated simulated EFV concentration-time profiles for six pregnancy/CYP2B6 scenarios with published Hep3B MitoSOX concentration-response data fitted with the Hill–Emax model. Translational exposure was evaluated as total hepatic EFV concentration relative to the nominal in vitro concentration range and as unbound hepatic concentration approximated from total plasma concentration and fraction unbound. Results: Simulations predicted lower total plasma exposure during pregnancy in the reference normal-metaboliser scenario (Cp,total Cmax: decreasing from 9.94 to 7.15 µM). Under the free-drug scenario (fu,p = 0.22%), the estimated Cmax,u decreased from 0.0219 to 0.0157 µM, remaining far below the lowest non-zero nominal in vitro concentration (10 µM). Benchmarked against the fu,vitro-corrected in vitro EC50 (0.324 μM via Kalvass–Maurer protein-binding correction), this margin narrowed to approximately 15- to 21-fold at the reference fu,p and to approximately 2-fold at the highest literature-reported value of fu,p (1.5%). Conclusions: Pregnancy and CYP2B6 phenotype altered simulated EFV exposure, whereas quantitative translation to the Hep3B oxidative stress response depended strongly on the concentration metric used. Because unbound EFV was not reported in the in vitro system and intracellular hepatic EFV was unavailable, neither comparison establishes a definitive effect-site match. This framework supports an exploratory QIVIVE interpretation and identifies the exposure measurements required for quantitative validation.
The comparison of adopter and non-adopter sample reveals three potential adoption inhibitor, security, data privacy, and portability, which underlines the importance of the technical and security perspectives for research investigating the adoption of technology.
Nattakarn Phaphoom, Xiaofeng Wang, S. Samuel et al.· Journal of Systems and Softw...· 111 citations· ⚡8
This study investigates how Lean internal startup facilitates software product innovation in large companies and identifies its enablers and inhibitors, and shows the potential of the method-in-action framework to investigate the Lean startup approach in non-startup context.
Henry Edison, Nina M. Smørsgård, Xiaofeng Wang et al.· Journal of Systems and Softw...· 78 citations· ⚡6
This paper highlights the challenges to conduct proper affect-related studies with psychology, provides a comprehensive literature review in affect theory, and proposes guidelines for conducting psychoempirical software engineering.
D. Graziotin, Xiaofeng Wang, P. Abrahamsson· SSE@SIGSOFT FSE· 56 citations· ⚡4
This study conducts a multiple case study on twenty European software startups and proposes a prototype-centric learning model in early stage software startups, and identifies factors that occur as barriers but also facilitators for prototyping in earlystage software startups.
Anh Nguyen-Duc, Xiaofeng Wang, P. Abrahamsson· International Conference on...· 44 citations· ⚡5
It is demonstrated that linker-free PROTACs can outperform traditional designs, marking a paradigm shift in PROTAC development for targeted protein degradation.
Pinal, a 16-billion-parameter foundation model that produces protein candidates from natural-language functional descriptions, supports natural language as a high-level interface for candidate generation in protein design, enabling programmable exploration with reduced reliance on manually specified structural or seque...
A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.